Your session is about to expire
← Back to Search
Initial Flow Rate for Bronchiolitis
Study Summary
This trial is testing whether high-flow nasal cannula (HFNC) therapy can help treat moderate to severe bronchiolitis in children less than 12 months old. The study will compare HFNC therapy at three different flow rates to see which is most effective. The primary outcome is a change in the Respiratory Assessment Change Score (RACS) after four hours of therapy.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does this investigation offer recruitment opportunities to those over seventy years of age?
"The requirements for this clinical trial necessitate that the participants are between 7 Days and 12 Months old. Additionally, 24 trials exist to serve people who are younger than 18 years of age while there are 18 studies specifically targeting those over 65."
What criteria must prospective volunteers meet to partake in this clinical experiment?
"This medical study is seeking 84 volunteers with bronchiolitis that fall between 7 days and 12 months old. Candidates must meet these criteria in order to participate."
Are there still opportunities available for individuals to participate in this research?
"The trial is still actively recruiting, as indicated on clinicaltrials.gov; it was first published in December of 2020 and the most recent update was released in June 2022."
How many participants are currently accepted into this medical research?
"Affirmative. According to information retrieved from clinicaltrials.gov, this medical study is open for recruitment and was first advertised on December 1st 2020. The last update occurred at the end of June 2022 with 84 participants required from a single site."
Share this study with friends
Copy Link
Messenger